Showing results (91-100 of 177) with videos related to

Sort By:
Pageof 18
JCO Oncology Practice|June 4, 2021
Oncology Patients' Perspectives on Remote Patient Monitoring for COVID-19Bobby Daly, Tara S Lauria, Jessie C Holland, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 25, 2024
First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast CancerRandy Yeh, Joseph A O'Donoghue, Vetri Sudar Jayaprakasam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Germline BRCA mutations denote a clinicopathologic subset of prostate cancerDavid J Gallagher, Mia M Gaudet, Prodipto Pal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2026
TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations in <i>PALB2</i> or Somatic Mutations in <i>BRCA1</i> or <i>BRCA2</i>Nadine M Tung, Mark E Robson, Tianyu Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2024
Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology GuidelineIsabelle Bedrosian, Mark R Somerfield, Maria Isabel Achatz, et al.
JCO Precision Oncology|May 26, 2021
Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic TestingElisha Hughes, Placede Tshiaba, Susanne Wagner, et al.
Pharmacogenetics and Genomics|July 11, 2020
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancerJames N Ingle, Krishna R Kalari, Poulami Barman, et al.
Molecular Endocrinology (Baltimore, Md.)|March 23, 2013
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expressionMohan Liu, James N Ingle, Brooke L Fridley, et al.
NPJ Breast Cancer|October 6, 2023
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO studyNicholas C Turner, A Douglas Laird, Melinda L Telli, et al.
Pageof 18